AcquisitionOther
Bristol Myers Squibb acquired 2seventy bio, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Bristol Myers Squibb -> 2seventy bio, Inc. · approximately $286 million
To acquire 2seventy bio which focused on unlocking the value of Abecma, ensuring this important therapy is delivered to patients who need it
Open source record (SEC) ↗